SOLICITATION NOTICE
A -- FY22 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
- Notice Date
- 11/10/2021 1:31:37 PM
- Notice Type
- Solicitation
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- FDA OFFICE OF ACQ GRANT SVCS Beltsville MD 20705 USA
- ZIP Code
- 20705
- Solicitation Number
- FDABAA-22-00123
- Response Due
- 1/21/2022 2:00:00 PM
- Archive Date
- 02/05/2022
- Point of Contact
- Robert Maydwell, Phone: 301-348-1814, Kimberly DeLong, Phone: 240-402-8639
- E-Mail Address
-
Robert.Maydwell@fda.hhs.gov, kimberly.delong@fda.hhs.gov
(Robert.Maydwell@fda.hhs.gov, kimberly.delong@fda.hhs.gov)
- Description
- In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities�acquired under this BAA�are intended�to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in�accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code ""AJ11"" specified in this announcement.� *This announcement is a renewal of the prior-year FY21 announcement (FDABAA-21-00123) and will remain open until further notice.�This announcement is renewed on an annual basis.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/c00c56895d2c45b1895ea60d0e4e4747/view)
- Place of Performance
- Address: Silver Spring, MD 20993, USA
- Zip Code: 20993
- Country: USA
- Zip Code: 20993
- Record
- SN06174980-F 20211112/211110230051 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |